Newsroom

NUEVA YORK--(BUSINESS WIRE)--Genius Sports Limited (NYSE: GENI), líder mundial en datos deportivos en tiempo real, presentó hoy un nuevo estudio biométrico realizado junto con MediaScience que demuestra que los anuncios emitidos inmediatamente después de momentos de gran intensidad emocional durante transmisiones deportivas en vivo pueden duplicar el recuerdo espontáneo de marca. El estudio, The Live Moment Effect, concluye que la efectividad publicitaria depende en gran medida del estado emoci...

NEW YORK--(BUSINESS WIRE)--Genius Sports Limited (NYSE: GENI), een wereldwijde leider op het gebied van realtime sportgegevens, heeft vandaag nieuw biometrisch onderzoek gepubliceerd dat samen met MediaScience is uitgevoerd. Hieruit blijkt dat advertenties die direct na emotioneel geladen momenten in live sport worden aangeboden, de spontane merkherkenning kunnen verdubbelen. Het onderzoek, The Live Moment Effect, toont aan dat de effectiviteit van advertenties sterk wordt beïnvloed door de emo...

NEW YORK--(BUSINESS WIRE)--Společnost Genius Sports Limited (NYSE: GENI), světový lídr v oblasti sportovních dat v reálném čase, dnes zveřejnila nový biometrický výzkum provedený ve spolupráci se společností MediaScience, který ukazuje, že reklamy vysílané bezprostředně po emocionálně nabitých momentech v živém sportovním vysílání mohou zdvojnásobit spontánní zapamatovatelnost značky. Studie s názvem Účinek živého okamžiku zjistila, že účinnost reklamy je významně ovlivněna emocionálním stavem...

NEW YORK--(BUSINESS WIRE)--Genius Sports Limited (NYSE: GENI), ein weltweit führender Anbieter von Echtzeit-Sportdaten, hat heute neue biometrische Forschungsergebnisse vorgestellt. Die gemeinsam mit MediaScience erarbeitete Studie zeigt, dass Werbung, die unmittelbar nach emotional besonders intensiven Momenten im Live-Sport ausgespielt wird, die ungestützte Markenerinnerung verdoppeln kann. The Live Moment Effect kommt zu dem Ergebnis, dass die Werbewirksamkeit maßgeblich von der emotionalen...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Hepcludex® (bulevirtide-gmod) 8.5 mg for the treatment of adults living with chronic hepatitis delta virus (HDV) infection, making it the first and only approved treatment for HDV in the United States. The FDA granted accelerated approval to Hepcludex based on reductions in HDV RNA and normalization of alanine aminotrans...

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of common stock of Coty Inc. (NYSE: COTY) between November 5, 2025 and February 4, 2026. Coty describes itself as a company that “together with its subsidiaries, manufactures, markets, distributes, and sells branded beauty products worldwide.”For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.The Alleg...

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV) on behalf of investors concerning the Company’s possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON CLARITEV CORPORATION (CTEV), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.What Is The Investigation About?On May 14, 2026, the Capitol Forum reported the U.S. Department of...

OLDWICK, N.J.--(BUSINESS WIRE)--Outbreaks of the Ebola virus and Andes hantavirus are putting a renewed focus on the insurance implications of rare communicable disease spreads and the need for proactive risk management, according to a new AM Best commentary. The Best’s Commentary, “Insurers Better Prepared For Rare Disease Outbreak Amid Lessons From COVID-19,” notes that health experts have said neither virus poses an immediate global threat nor is expected to spread anywhere near the scale of...

CHARLOTTE, N.C.--(BUSINESS WIRE)--Please replace the release dated April 14, 2026 with the following corrected version to replace references to HITRUST with references to HIPAA/HITECH. The updated release reads:  PCI PAL RAISES THE BAR FOR PAYMENT SECURITY WITH SOC2 TYPE II WITH HIPAA/HITECH ATTESTATION PCI Pal® (LON: PCIP), the global provider of secure payment solutions, has further strengthened its position as a trusted enterprise partner with the achievement of SOC 2 Type II attestation, de...

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) investors concerning the Company’s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON GE HEALTHCARE TECHNOLOGIES INC. (GEHC), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened...